Status:
COMPLETED
The Utility of Long-acting Local Anesthetic Agents in Reducing Post-operative Opioid Requirements Following Rhinoplasty
Lead Sponsor:
Our Lady of the Lake Hospital
Collaborating Sponsors:
Louisiana State University Health Sciences Center in New Orleans
Conditions:
Pain, Postoperative
Local Anesthetic
Eligibility:
All Genders
18-100 years
Phase:
EARLY_PHASE1
Brief Summary
On average, more than 130 Americans die every day from opioid overdose. Surgeons provide 37% of all opioid prescriptions in the United states, second only behind pain management physicians. A recent r...
Detailed Description
The local anesthesia regimen administered prior to surgery is a standard practice for rhinoplasty procedures. However, there is variation in the kind of anesthetic utilized during this time. In our pr...
Eligibility Criteria
Inclusion
- ages 18 and over
- undergoing external rhinoplasty
Exclusion
- Pre-existing chronic pain within 30 days prior to surgery
- Opioid use within 30 days before their surgery
- Patients undergoing a concurrent procedure (i.e. facial rejuvenation)
Key Trial Info
Start Date :
June 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2022
Estimated Enrollment :
5 Patients enrolled
Trial Details
Trial ID
NCT04377204
Start Date
June 1 2020
End Date
December 31 2022
Last Update
March 23 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Our Lady of the Lake Hospital
Baton Rouge, Louisiana, United States, 70808